These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16646683)

  • 1. Impact of short-term hypothyroidism on systemic anticoagulation in patients with thyroid cancer and coumarin therapy.
    Bucerius J; Joe AY; Palmedo H; Reinhardt MJ; Biersack HJ
    Thyroid; 2006 Apr; 16(4):369-74. PubMed ID: 16646683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical hyperthyroidism seems not to have a significant impact on systemic anticoagulation in patients with coumarin therapy.
    Bucerius J; Naubereit A; Joe AY; Ezziddin S; Biermann K; Risse J; Palmedo H; Oldenburg J; Biersack HJ
    Thromb Haemost; 2008 Nov; 100(5):803-9. PubMed ID: 18989524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis.
    Bucerius J; Ezziddin S; Brockmann H; Palmedo H; Biersack HJ
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):606-9. PubMed ID: 17943696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and severity of hyponatremia and hypercreatininemia in short-term uncomplicated hypothyroidism.
    Baajafer FS; Hammami MM; Mohamed GE
    J Endocrinol Invest; 1999 Jan; 22(1):35-9. PubMed ID: 10090135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal thyrotropin secretion in short-term profound primary hypothyroidism: does it ever persist?
    Hirshberg B; Veldhuis JD; Sarlis NJ
    Thyroid; 2000 Dec; 10(12):1101-6. PubMed ID: 11201856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International normalized ratio stability in warfarin-experienced patients with nonvalvular atrial fibrillation.
    Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):205-11. PubMed ID: 25944648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients.
    Baruch L; Sherman O
    Ann Pharmacother; 2013 Sep; 47(9):1210-2. PubMed ID: 24259738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin.
    Kim JS; Jongnarangsin K; Latchamsetty R; Chugh A; Ghanbari H; Crawford T; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):302-9. PubMed ID: 23443620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin interactions with antibiotics in the ambulatory care setting.
    Clark NP; Delate T; Riggs CS; Witt DM; Hylek EM; Garcia DA; Ageno W; Dentali F; Crowther MA;
    JAMA Intern Med; 2014 Mar; 174(3):409-16. PubMed ID: 24445404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
    Shimon I; Cohen O; Lubetsky A; Olchovsky D
    Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
    Watzke HH; Forberg E; Svolba G; Jimenez-Boj E; Krinninger B
    Thromb Haemost; 2000 May; 83(5):661-5. PubMed ID: 10823258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
    Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
    Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.